僑銀環保(002973.SZ)擬3500萬元建病死禽畜集中無害化處理場項目
格隆匯2月17日丨僑銀環保(002973.SZ)公佈,2020年2月17日,公司與安福縣人民政府共同簽署了《安福畜禽無害化處理項目協議書》。公司擬以自籌資金投資約3500萬元建設病死禽畜集中無害化處理場項目,項目建成後,將達到每年處理10萬頭病死禽畜的規模,對實現禽畜養殖廢棄物的資源化利用,建立循環經濟產業鏈,改善農村生活環境,促進生態農業發展具有積極的作用。
此次投資符合公司戰略發展規劃,是公司“城市大管家”與“環保創新技術”雙輪驅動戰略下的又一舉措,本次投資將對實現禽畜養殖廢棄物的資源化利用,建立循環經濟產業鏈,對改善農村生活環境,促進生態農業發展具有積極的作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.